Sun Pharmaceutical Industries Ltd today said it has received an approval from the US health regulator to sell generic drug galantamine hydrobromide used in treating mild to moderate Alzheimer's disease,
Sun Pharmaceutical Industries today announced that its US-based subsidiary has got tentative approval from the Food and Drug Administration to market a generic drug for the treatment of Alzheimer's disease.
Sun Pharmaceutical Industries today reported a decline of 11 per cent.
Sun Pharmaceutical Industries has extended the open offer, which was to expire t
Its bid to acquire Israel's Taro may be stuck in legal wrangles, but Mumbai-base
The on-going tussle between Sun Pharmaceutical and Taro intensified today with the Mumbai-based company saying it has exercised the option of
Stay informed on our latest news!
